Real-World Data on GLP-1 Receptor Agonists Highlight Benefits and Risks
Emerging real-world data are shaping debates on GLP-1 receptor agonists’ effectiveness and safety, influencing weight and metabolic care decisions for patients and clinicians managing diabetes and obesity.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.